1. Home
  2. PPBT vs WORX Comparison

PPBT vs WORX Comparison

Compare PPBT & WORX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PPBT
  • WORX
  • Stock Information
  • Founded
  • PPBT 2010
  • WORX N/A
  • Country
  • PPBT Israel
  • WORX United States
  • Employees
  • PPBT N/A
  • WORX N/A
  • Industry
  • PPBT Biotechnology: Pharmaceutical Preparations
  • WORX Services-Misc. Amusement & Recreation
  • Sector
  • PPBT Health Care
  • WORX Consumer Discretionary
  • Exchange
  • PPBT Nasdaq
  • WORX Nasdaq
  • Market Cap
  • PPBT 2.1M
  • WORX 2.5M
  • IPO Year
  • PPBT N/A
  • WORX N/A
  • Fundamental
  • Price
  • PPBT $0.57
  • WORX $0.31
  • Analyst Decision
  • PPBT Strong Buy
  • WORX
  • Analyst Count
  • PPBT 1
  • WORX 0
  • Target Price
  • PPBT $33.00
  • WORX N/A
  • AVG Volume (30 Days)
  • PPBT 2.8M
  • WORX 8.1M
  • Earning Date
  • PPBT 08-06-2025
  • WORX 08-14-2025
  • Dividend Yield
  • PPBT N/A
  • WORX N/A
  • EPS Growth
  • PPBT N/A
  • WORX N/A
  • EPS
  • PPBT N/A
  • WORX N/A
  • Revenue
  • PPBT N/A
  • WORX $2,838,404.00
  • Revenue This Year
  • PPBT N/A
  • WORX N/A
  • Revenue Next Year
  • PPBT N/A
  • WORX N/A
  • P/E Ratio
  • PPBT N/A
  • WORX N/A
  • Revenue Growth
  • PPBT N/A
  • WORX N/A
  • 52 Week Low
  • PPBT $0.53
  • WORX $0.26
  • 52 Week High
  • PPBT $13.95
  • WORX $3.31
  • Technical
  • Relative Strength Index (RSI)
  • PPBT 11.95
  • WORX 46.96
  • Support Level
  • PPBT $0.53
  • WORX $0.28
  • Resistance Level
  • PPBT $2.36
  • WORX $0.36
  • Average True Range (ATR)
  • PPBT 0.16
  • WORX 0.06
  • MACD
  • PPBT -0.13
  • WORX 0.00
  • Stochastic Oscillator
  • PPBT 2.05
  • WORX 11.88

About PPBT Purple Biotech Ltd.

Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, and to create treatments for people with cancer. Its oncology pipeline includes NT219: A dual inhibitor, small molecule that simultaneously targets Insulin Receptor Substrate 1 and 2 (IRS1/2) and Signal Transducer and Activator of Transcription (STAT3), two survival signal transduction pathways driving the development of cancer drug resistance. and CM24: is a humanized monoclonal antibody designed to block the interactions of Carcinoembryonic Antigen Related Cell Adhesion Molecule 1 (CEACAM1), a glycoprotein that plays a key role in immune regulation, cell adhesion, and tumor progression, CAPTN3.

About WORX SCWorx Corp.

SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications, and provides the basis for sophisticated data analytics. The company has developed and markets healthcare information technology solutions and associated services to improve healthcare processes and information flow within hospitals and other healthcare facilities.

Share on Social Networks: